Global Antidote Market, By Type, By Route of Administration, By End User, By Geography

Description

The global antidote market size is expected to reach US$ 4.58 Bn by 2030, from US$ 2.70 Bn in 2023, exhibiting a CAGR of 7.8% during the forecast period.

Report Coverage		Report Details
Base Year:	2022	Market Size in 2023/2024:	US$ 2.70 Bn
Historical Data for:	2017 to 2021	Forecast Period:	2023 - 2030
Forecast Period 2023/2024 to 2030/2031 CAGR:	7.80%	2030/2031 Value Projection:	US$ 4.58 Bn

Figure 1. Global Antidote Market Share (%), By Region, 2023

The global antidote market has been witnessing steady growth over the past few years owing to the growing incidence of poisoning cases across the world. Poisoning can occur accidentally or intentionally through the consumption of toxic chemicals, drugs, or other harmful substances. Antidotes are pharmaceutical preparations administered to counteract the effects of poisons, toxins, or certain disease states. They work by blocking the mechanisms through which poisons produce their toxic effects in the body. With rising environmental pollution and drug abuse in modern times, the need for effective antidotal treatments for poisoning is increasing continuously. The market offers a wide range of antidotes for common poisoning cases involving opioids, organophosphates, methanol, chloroquine, and other toxic agents. Leading players are focusing on developing novel formulations with better efficacy and safety profiles to cater to unmet needs.

Market Dynamics:

The increasing incidence of accidental and intentional poisoning worldwide is a major driver for the antidote market. Growing environmental pollution and industrial waste have simultaneously increased exposure to toxic chemicals. A significant rise in substance abuse disorders has also heightened poisoning risks from overdoses of prescription medications and recreational drugs. However, high costs associated with antidote production, the short shelf life of some products, and the lack of availability in remote regions restrict broader market uptake to some extent. On the other hand, ongoing research and development into advanced therapeutic alternatives and expanding healthcare access in emerging nations are expected to create new opportunities. The development of antidotes for specialty toxins and bioterrorism agents also holds promising prospects. For instance, in March 2022, according to a report published by the National Center for Biotechnology Information, approximately 121,729 fatalities were reported due to drug overdose in 2021, in the U.S. Additionally, the rising occurrence of medical issues that require the use of antidotes, including preventative treatment for pneumonia, aid in quitting smoking, treatment for toxoplasmosis, countering opioid overdose, reversing opioid-induced sedation, addressing trichotillomania, and reversing sedation, is propelling market expansion.

Key features of the study:

This report provides in-depth analysis of the global antidote market, and provides market size (US$ Bn) and compound annual growth rate (CAGR%) for the forecast period (2023-2030), considering 2022 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global antidote market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
Key companies covered as a part of this study include Dr. Reddy's Laboratories Ltd Viatris Inc., Fresenius Kabi AG, Zydus Lifesciences Ltd., Endo International plc, Novartis AG, Baxter International, Inc., Emergent BioSolutions Inc., Pfizer Inc., Hikma Pharmaceuticals PLC, Incepta Pharma, VINS Bioproducts Ltd Bharat Serums and Vaccines Limited, CSL Limited, Mediclone Biotech, Shanghai Serum Bio-technology Co., LTD., Haffkine Bio-pharmaceutical Corporation Ltd. and Premium Serums
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
The global antidote market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global antidote market

Detailed Segmentation:

Global Antidote Market, By Type
- Chemical Antidote
- Physical Antidote
- Pharmacological Antidote
Global Antidote Market, By Route of Administration
- Oral
- Topical
- Injectable
- Others
Global Antidote Market, By End User
- Hospitals
- Speciality Clinics
- Others
Global Antidote Market, By Region
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East
- Africa
Global Antidote Market, Key Players
- Reddy's Laboratories Ltd
- Viatris Inc.
- Fresenius Kabi AG
- Zydus Lifesciences Ltd.
- Endo International plc
- Novartis AG
- Baxter International, Inc.
- Emergent BioSolutions Inc.
- Pfizer Inc.
- Hikma Pharmaceuticals PLC
- Incepta Pharma
- VINS Bioproducts Ltd
- Bharat Serums and Vaccines Limited
- CSL Limited
- Mediclone Biotech
- Shanghai Serum Bio-technology Co., LTD.
- Haffkine Bio-pharmaceutical Corporation Ltd.
- Premium Serums

Product Code: CMI6537

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Global Antidote Market, By Type
- Global Antidote Market, By Route of Administration
- Global Antidote Market, By End User
- Global Antidote Market, By Region
Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
- Rise in cases of accidental poisoning
- Stringent regulations for approval of antidotes
- Increasing demand for generic antidotes
Impact Analysis
Key Highlights
Regulatory Scenario
Service offering Portfolio
PEST Analysis
PORTER's Analysis
Merger and Acquisition Scenario

4. Global Antidote Market- Impact of Coronavirus (COVID-19) Pandemic

COVID-19 Epidemiology
Supply Side and Demand Side Analysis
Economic Impact

5. Global Antidote Market, By Type, 2018-2030, (US$ Bn)

Introduction
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2019 - 2030
- Segment Trends
Chemical Antidote
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
Physical Antidote
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
Pharmacological Antidote
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)

6. Global Antidote Market, By Route of Administration, 2018-2030, (US$ Bn)

Introduction
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2019 - 2030
- Segment Trends
Oral
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
Topical
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
Injectable
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)

7. Global Antidote Market, By End User, 2018-2030, (US$ Bn)

Introduction
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2019 - 2030
- Segment Trends
Hospitals
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
Speciality Clinics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)

8. Global Antidote Market, By Region, 2018-2030, (US$ Bn)

Introduction
- Market Share Analysis, By Country, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, For Country 2019 -2030
- Country Trends
North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2018-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2018-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030,(US$ Bn)
U.S.
Canada
Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2018-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2018-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030,(US$ Bn)
Germany
U.K.
Spain
France
Italy
Russia
Rest of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2018-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2018-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030,(US$ Bn)
China
India
Japan
Australia
South Korea
ASEAN
Rest of Asia Pacific
Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2018-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2018-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030,(US$ Bn)
Brazil
Argentina
Mexico
Rest of Latin America
Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2018-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2018-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030,(US$ Bn)
GCC Countries
Israel
Rest of Middle East
Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2018-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2018-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2018-2030,(US$ Bn)
North Africa
Central Africa
South Africa

9. Competitive Landscape

Reddy's Laboratories Ltd
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Viatris Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Fresenius Kabi AG
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Zydus Lifesciences Ltd.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Endo International plc
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Novartis AG
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Strategies
Baxter International, Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Emergent BioSolutions Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Pfizer Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Hikma Pharmaceuticals PLC
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Incepta Pharma
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
VINS Bioproducts Ltd
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Bharat Serums and Vaccines Limited
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
CSL Limited
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Mediclone Biotech
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Shanghai Serum Bio-technology Co., LTD.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Haffkine Bio-pharmaceutical Corporation Ltd.
Premium Serums
Analyst Views

10. Section

Research Methodology
About us